在不确定区域的低频刺激通过驱动GABAergic神经元活动减轻了发作
Mengdi Zhang1, Lin Yang2, Zhongxia Li3
1Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China; Zhejiang Rehabilitation Medical Center, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, PR China.
Neurobiology of disease
|January 30, 2024
概括
在不确定的区域 (ZI) 进行深度大脑刺激 (DBS),通过激活GABAergic神经元,有效地降低了发作的严重程度. 低频DBS,特别是5Hz,显示出最佳的抗发作效果,突出ZI作为治疗的有希望的目标.
科学领域:
- 神经科学是一个神经科学.
- 发病学 (Epileptology) 是一个专业的学科.
- 神经调节是一种神经调节.
背景情况:
- 耐火性是一种重大的临床挑战.
- 深度大脑刺激 (DBS) 是一个有前途的治疗方法,但最佳的目标和参数仍然不清楚.
- 不确定区 (ZI) 正被调查为潜在的DBS目标.
研究的目的:
- 评估DBS在ZI的治疗潜力,用于各种发作模型.
- 阐明DBS在ZI的有效性背后的机制.
- 为了确定ZIGABAergic神经元在DBS介导的控制中的作用.
主要方法:
- DBS被应用于卡因酸 (KA) 诱导的TLE,皮洛卡尔宾诱导和KA诱导的皮质发作模型中的ZI.
- 用纤维光度和细胞特异性除来研究ZIGABAergic神经元活动.
- 测试了DBS频率,包括5Hz等低频率.
主要成果:
- 在ZI中,DBS在多种模型 (TLE,皮质) 中减轻了发作的严重程度.
- 低频 DBS (5 Hz) 显示出最佳的抗发作疗效.
- 低频DBS增加了ZIGABAergic神经元活动,其切除阻断了抗发作效应.
结论:
- 在ZI中低频DBS通过激活GABAergic神经元来减轻发作.
- ZI是海马和皮质发作的潜在DBS目标.
- 激活ZIGABAergic神经元对管理具有治疗意义.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
689
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
689
01:24Epilepsy and Seizures: Overview
297
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
297
01:14Antiepileptic Drugs: Glutamate Antagonists
530
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
530
01:17Antiepileptic Drugs: Calcium Channel Blockers
659
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
659